Which of the following options is NOT a purpose of conducting Phase IV clinical trials?

Question

BlackTom AI · Accepted Answer

Phase IV (post‑marketing) clinical trials are primarily focused on monitoring a drug after regulatory approval to collect real‑world evidence about safety, effectiveness, and use in broader populations.

1) Relevant knowledge points and concepts:
- Clinical trial phases: Phase I (safety/dose), Phase II (efficacy/safety), Phase III (large efficacy/safety for approval), Phase IV (post‑marketing surveillance).
- Phase IV objectives: detect rare or long‑latency adverse events, assess long‑term safety and effectiveness in routine clinical use, evaluate performance in subgroups under‑represented in pre‑approval trials, study drug interactions, adherence, and outcomes in diverse real‑world settings.

2) Step‑by‑step reasoning:
- Step 1: Identify the core purpose of Phase IV: post‑approval surveillance and additional data collection in the real world.
- Step 2: Compare each option to that purpose.
  - Option b describes identifying rare side effects; this directly matches post‑marketing pharmacovigilance.
  - Option c describes gathering long‑term real‑world safety/effectiveness data; that is a central Phase IV goal.
  - Option d describes studying under‑represented patient groups; Phase IV frequently targets these groups to fill gaps from earlier phases.
  - Option a claims Phase IV is to support marketing by demonstrating superiority over competitors. While industry may use Phase IV data in promotional materials, designing trials principally to advertise superiority is not a scientific or regulatory purpose of Phase IV and is inconsistent with the regulatory/post‑marketing surveillance role.

3) Calculations: none required.

4) Why the correct answer is correct:
- Option a is NOT a legitimate primary purpose of Phase IV trials; the legitimate aims are safety, effectiveness, and population‑specific data. Marketing support is not an objective recognized by regulators as the purpose of post‑marketing studies.

5) Why other options are incorrect (i.e., they are true purposes):
- b, c, and d each describe typical and appropriate aims of Phase IV and therefore are not the correct choice for "NOT a purpose."

Conclusion: The correct answer is a. To support marketing campaigns by demonstrating a drug's superiority over competitors. This matches the provided answer.

Which of the following options is NOT a purpose of conducting Phase IV clinical trials?单项选择题

类似问题

Which of the following options does NOT describe what interim analysis can lead to?

Which of the following best describes an adaptive trial design?

You own a bond that pays $64 in interest annually. The face value is $1,000 and the current market price is $1,021.61. The bond matures in 11 years. What is the yield to maturity?

Which of the following statements is CORRECT?

It will cost $9,600 to acquire an ice cream cart that is expected to produce cash inflows of $3,600 a year for three years. After the three years, the cart is expected to be worthless. What is the payback period?

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单